Results 191 to 200 of about 24,920 (225)

Mutations in the NS5 RdRp Domain of Zika and Dengue Viruses: Insights into Molecular Patterns in Inland Midwestern Brazil. [PDF]

Trop Med Infect Dis
Roma JHF, Alves RC, Carneiro BM, Slhessarenko RD, Chavez-Pavoni JH, Resende MR.   +5 more
europepmc   +1 more source

Advances in anti-dengue virus properties of Traditional Chinese Medicines. [PDF]

Front Microbiol
Zeng R, Wu T, Zheng K, Zhang L, Sun F, Yuan S, Huang S, Wang F, Dai Z, Zhou J, Li S, Hu D, Shi Y, Dai J.   +13 more
europepmc   +1 more source

Comment on: Pettersson et al. Qdenga-induced dengue caused by minor DENV-2 subvariant(s) in the vaccine, with two amino acid substitutions in the E protein. [PDF]

J Travel Med
Tricou V, Livengood J, Sharma M, Zent O, Rauscher M, Setoh YX, Brünner C, Biswal S, Kandeil W.   +8 more
europepmc   +1 more source

Locally Acquired Dengue in Townsville, Australia, 2024-2025: An Outbreak Report in a Non-Endemic Region with <i>w</i>Mel <i>Wolbachia</i>-Infected <i>Aedes aegypti</i>. [PDF]

Trop Med Infect Dis
Thompson K, Lyons S, Malone K, Fryk J, Pyke A, Murton K.   +5 more
europepmc   +1 more source

Correction for Wang et al., Mechanistic insights into dengue virus inhibition by a clinical trial compound NITD-688. [PDF]

Proc Natl Acad Sci U S A
europepmc   +1 more source

Seroprevalence of Dengue, Chikungunya and Rift Valley fever virus IgG antibodies in Kenyan blood donors

Nyagwange J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Silent spread of DENV-3 in Brazil: autochthonous outbreak in São Paulo after 15 years

Journal of Travel Medicine, 2023
The high incidence of dengue in Brazil and re-emergence of DENV-3 in São Paulo after a 15-year absence, coupled with the potential risk for DENV-4, may be the results from changing climate patterns favouring Aedes mosquito proliferation, allied by the resuming of domestic and international travels.
Dennis M Fujita, Felipe S Salvador, Luiz H da Silva Nali, Heitor F de Andrade Júnior   +3 more
openaire   +2 more sources

All-Atom Perspective of the DENV-3 Methyltransferase Inhibition Mechanism

The Journal of Physical Chemistry B
The Dengue virus (DENV) is an enveloped, single-stranded RNA virus with several antigenically distinct serotypes (DENV-1 to DENV-5). Dengue fever, as a major public health threat transmitted by mosquitoes, affects millions of people worldwide (especially in tropical and subtropical regions). Toward drug developments of DENV, the nonstructural protein 5
Xiao Liu, Kaiwen Pang, Hangfei Wu, Xiaohui Wang, John Z. H. Zhang, Zhaoxi Sun   +5 more
openaire   +2 more sources

Virtual Screening-Based Identification of Potent DENV-3 RdRp Protease Inhibitors via In-House Usnic Acid Derivative Database

Journal of Computational Biophysics and Chemistry, 2021
Dengue virus (DENV) is the causative agent of dengue fever, dengue hemorrhagic disease and dengue shock syndrome (DSS), transmitted predominantly in tropical and subtropical regions by Aedes aegypti. It infects millions of people and causes thousands of deaths each year, but there is no antiviral drug against DENV.
Miah Roney, AKM Moyeenul Huq, Kamal Rullah, Hazrulrizawati Abd Hamid, Syahrul Imran, Md. Alimul Islam, Mohd Fadhlizil Fasihi Mohd Aluwi   +6 more
openaire   +1 more source

Comparative Phylogenetic Analysis and Transcriptomic Profiling of Dengue (DENV-3 genotype I) Outbreak in 2021 in Bangladesh

2022
AbstractObjectivesThe lack of a dengue disease animal model and the complex immune interaction in dengue infection hinders the study of host response and immunopathogenesis. The development of next-generation sequencing (NGS) technology allowed the researchers to study the transcriptomic profiles of human in-depth.
Md. Murshed Hasan Sarkar, M. Shaminur Rahman, M. Rafiul Islam, Arafat Rahman, Md. Shariful Islam, Tanjina Akhtar Banu, Shahina Akter, Barna Goswami, Iffat Jahan, Md Ahashan Habib, Mohammad Mohi Uddin, Md. Ibrahim Miah, Aftab Ali Shaikh, Md. Salim Khan   +13 more
openaire   +1 more source